Anne W. Beaven

Hematology Lead/Developer of the UNC Multidisciplinary Cutaneous Lymphoma Clinic · University of North Carolina at Chapel Hill

Credentials: · ·

History

UNC Multidisciplinary Cutaneous Lymphoma Clinic · University of North Carolina at Chapel Hill
Present

CD30 CAR for Relapsed/Refractory CD30+ T Cell Lymphoma
Principal investigator · Recruiting · Phase 2
UNC Lineberger Comprehensive Cancer Center
2019–2038
Phase II Trial to Evaluate an EBV-derived Dendritic Cell Vaccine in Autologous Stem Cell Transplant
Principal investigator · Withdrawn · Phase 2
David Rizzieri, MD
2016–2025
Ph1 Volasertib Plus Romidepsin in R/R PTCL and CTCL
Principal investigator · Withdrawn · Phase 1
Anne Beaven, MD
2016
Study of CD30 CAR for Relapsed/Refractory CD30+ HL and CD30+ NHL
Principal investigator · Active not recruiting · Phase 1, Phase 2
UNC Lineberger Comprehensive Cancer Center
2016–2039